Journal
Spotlights
Webinars
Channels
Analytics
Manufacturing
Vectors
Regulatory
Supply Chain
Translational Research & Clinical Development
Business and Finance
Reports
Regulatory Insights
Clinical Trends
Innovation Insights
Business Insights
Investor Insights
FastFacts
Media Kit
Media Kit
Editorial calendar
Sponsorship opportunities
Webinars
About
Submit your manuscript
Meet the team
Get in touch
Immuno-Oncology Insights
Login
Register
Update your profile
Logout
CELL & GENE THERAPY
INSIGHTS
Immuno-oncology: manufacturing and commercial business models for the new decade
Guest Editor:
Usman Azam, President & CEO at Tmunity Therapeutics Inc
Usman Azam
President & CEO at Tmunity Therapeutics Inc
July 2020
Sponsors
Download full spotlight
Decentralized manufacturing: from stem cell transplants to the next generation of cellular immunotherapies
M Li,
S Kassim
18 June 2020
Expert Insight
Read more
Immuno-oncology: manufacturing and commercial business models for the new decade – Foreword
U Azam
28 July 2020
Foreword
Read more
Expert Roundtable: evolving autologous and allogeneic cell therapy manufacturing models in the commercial setting
D Adams,
G Russotti,
J Lunger
et al.
17 July 2020
Expert Roundtable Video
Watch now
Simplifying GMP CART and CAR NK cell therapy manufacturing processes
S Dluczek,
K Fynes,
S Fricke
et al.
16 July 2020
Innovator Insight
Read more
Evolving autologous and allogeneic cell therapy manufacturing models in the commercial setting
D Adams,
G Russotti,
J Lunger
et al.
16 July 2020
Expert Roundtable
Read more
Manufacturing of endogenous, non-engineered, antigen specific T cells against tumor targets
Ali Mohamed, Vice President, CMC at Immatics
Megan Ciarlo, Technology & Applications Specialist at Miltenyi Biotec
14 July 2020
Webinar
Watch now
Current and future directions for tumor infiltrating lymphocyte therapy for the treatment of solid tumors
M Fardis,
K DiTrapani,
F Finckenstein
et al.
3 July 2020
Expert Insight
Read more
Innovating CAR T cell therapy for today and tomorrow
D Chang
30 June 2020
Expert Insight
Read more
Immuno-oncology cell therapies: commercial considerations and strategies for the new decade
G Firestone
30 June 2020
Expert Insight
Read more
Commercialization of TCR T-cell therapy: patient journey implications
K Freeman
17 June 2020
Expert Insight
Read more
Looking to the future of stem cell-derived immunotherapy
P Zandstra
17 June 2020
Interview
Read more
Understanding the drivers of success and failure in CAR T cell therapy
J Melenhorst
16 June 2020
Interview
Read more
Challenges of cell collections for cell therapy manufacturing: what do we want in the bag?
Elizabeth Valdez, RN & MSN Global Trainer at Terumo BCT
Jim Beltzer, Global Strategy Lead, Cell Therapy
Sandeep Soni, Associate Professor, Pediatric Stem Cell Transplant, Gene Therapy & Regenerative Medicine at Stanford University School of Medicine
Melinda Caltabiano, Director, Apheresis Operations at Dendreon Pharmaceuticals
Krishnendu Roy, Professor, Director, Marcus Center for Therapeutic Cell Characterization & Manufacturing (MC3M) at Georgia Institute of Technology
24 June 2020
Webinar
Watch now
Simplifying GMP CAR-T and CAR NK cell therapy manufacturing processes
Martha Luevano, Global Product Manager at Miltenyi Biotec
Xiuyan Wang, Assistant Director, Michael G. Harris Cell Therapy & Cell Engineering Facility at Memorial Sloan-Kettering Cancer Center
Stephan Fricke, Head of GMP Process Development at Fraunhofer Institute for Cell Therapy & Immunology IZI
Sarah Dluczek, Technical Leader, GMP Unit at Fraunhofer Institute for Cell Therapy & Immunology IZI
Kate Fynes, Process Development Investigator, Cell & Gene Therapy CMC at GlaxoSmithKline
Ulrike Koehl, Director & Head, Institute of Cell Therapeutics & GMP Development Unit at Hannover Medical School
9 June 2020
Webinar
Watch now
×
Please enter your email to register
Register